|
Market Closed -
Other stock markets
|
After hours 20:59:55 | |||
| 57.50 EUR | -2.08% |
|
57.60 | +0.17% |
| 11-05 | CAC40 Attempts to Avoid a Seventh Consecutive Decline, Buoyed by Nasdaq Rebound | |
| 11-05 | Paris Slows Further as Market Correction Looms |
Company Valuation: Eurofins Scientific SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 13,091 | 20,893 | 12,900 | 11,336 | 9,273 | 10,194 | - | - |
| Change | - | 59.6% | -38.26% | -12.13% | -18.2% | 9.93% | - | - |
| Enterprise Value (EV) 1 | 15,333 | 23,132 | 15,739 | 14,041 | 12,269 | 13,868 | 13,661 | 13,193 |
| Change | - | 50.86% | -31.96% | -10.79% | -12.62% | 13.03% | -1.49% | -3.42% |
| P/E ratio | 25x | 27.8x | 22.2x | 45.4x | 26.9x | 22.4x | 18.9x | 15.7x |
| PBR | 3.55x | 4.49x | 2.7x | 2.24x | 1.73x | 1.97x | 1.79x | 1.64x |
| PEG | - | 0.7x | -1x | -0.8x | 0.7x | 0.6x | 1x | 0.8x |
| Capitalization / Revenue | 2.41x | 3.11x | 1.92x | 1.74x | 1.33x | 1.39x | 1.32x | 1.23x |
| EV / Revenue | 2.82x | 3.44x | 2.34x | 2.16x | 1.77x | 1.89x | 1.76x | 1.59x |
| EV / EBITDA | 10.9x | 12.2x | 10.4x | 10.3x | 7.91x | 8.6x | 7.82x | 6.91x |
| EV / EBIT | 15x | 15.7x | 15.2x | 16.7x | 12.1x | 13.2x | 11.9x | 10.3x |
| EV / FCF | 17.6x | 22.8x | 23.2x | 29.6x | 15.3x | 37.5x | 19.6x | 16.7x |
| FCF Yield | 5.69% | 4.39% | 4.3% | 3.38% | 6.53% | 2.66% | 5.1% | 5.98% |
| Dividend per Share 2 | 0.68 | 1 | 1 | 0.5 | 0.5 | 0.635 | 0.6967 | 0.779 |
| Rate of return | 0.99% | 0.92% | 1.49% | 0.85% | 1.01% | 1.1% | 1.21% | 1.35% |
| EPS 2 | 2.75 | 3.91 | 3.02 | 1.3 | 1.83 | 2.571 | 3.036 | 3.666 |
| Distribution rate | 24.7% | 25.6% | 33.1% | 38.5% | 27.3% | 24.7% | 22.9% | 21.2% |
| Net sales 1 | 5,439 | 6,718 | 6,712 | 6,515 | 6,951 | 7,326 | 7,742 | 8,279 |
| EBITDA 1 | 1,413 | 1,902 | 1,513 | 1,364 | 1,552 | 1,613 | 1,748 | 1,909 |
| EBIT 1 | 1,024 | 1,473 | 1,037 | 842 | 1,017 | 1,053 | 1,148 | 1,285 |
| Net income 1 | 539.4 | 783 | 606 | 310 | 406 | 480.3 | 572.3 | 696.6 |
| Net Debt 1 | 2,242 | 2,239 | 2,839 | 2,705 | 2,996 | 3,674 | 3,467 | 2,999 |
| Reference price 2 | 68.63 | 108.80 | 67.06 | 58.98 | 49.31 | 57.50 | 57.50 | 57.50 |
| Nbr of stocks (in thousands) | 190,749 | 192,035 | 192,365 | 192,194 | 188,049 | 177,284 | - | - |
| Announcement Date | 01/03/21 | 22/02/22 | 01/03/23 | 27/02/24 | 30/01/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 22.84x | 1.92x | 8.73x | 1.08% | 12.07B | ||
| 37.37x | 5.47x | 18.41x | 0.93% | 47.62B | ||
| 126x | 7.48x | 76.38x | -.--% | 41.68B | ||
| 30.52x | 3.1x | 13.37x | -.--% | 36.81B | ||
| 52.77x | 10.31x | 29.54x | 0.39% | 28.65B | ||
| 39.57x | 6.41x | 29.12x | -.--% | 16.5B | ||
| -12.32x | 4534.88x | -11.69x | -.--% | 13.37B | ||
| -59.42x | 15.76x | -139.09x | -.--% | 13.23B | ||
| 24.23x | 1.85x | 9.48x | -.--% | 11.95B | ||
| -44.05x | 9.68x | 29226.49x | -.--% | 11.81B | ||
| Average | 21.75x | 459.69x | 2,926.07x | 0.24% | 23.37B | |
| Weighted average by Cap. | 40.28x | 265.61x | 1,494.76x | 0.29% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- ERF Stock
- Valuation Eurofins Scientific SE
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















